These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 38066723)

  • 1. Pathogenesis and management of immune dysfunction secondary to B cell haematological malignancies.
    Crassini K; Gibson J
    Intern Med J; 2024 Jan; 54(1):16-25. PubMed ID: 38066723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
    Plosker GL; Figgitt DP
    Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B-Cell Malignancies: The Use of Small Molecule Agents for Treatment and Management.
    Rogers BB
    Clin J Oncol Nurs; 2020 Apr; 24(2):199-204. PubMed ID: 32196006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rituximab: a review of its use in chronic lymphocytic leukaemia, low-grade or follicular lymphoma and diffuse large B-cell lymphoma.
    Keating GM
    Drugs; 2010 Jul; 70(11):1445-76. PubMed ID: 20614951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Updates on Hematologic Malignancies in the Older Adult: Focus on Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, and Multiple Myeloma.
    Huang LW; Wong SW; Andreadis C; Olin RL
    Curr Oncol Rep; 2019 Mar; 21(4):35. PubMed ID: 30848394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Addition of Rice Bran Arabinoxylan to Curcumin Therapy May Be of Benefit to Patients With Early-Stage B-Cell Lymphoid Malignancies (Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma, or Stage 0/1 Chronic Lymphocytic Leukemia): A Preliminary Clinical Study.
    Golombick T; Diamond TH; Manoharan A; Ramakrishna R
    Integr Cancer Ther; 2016 Jun; 15(2):183-9. PubMed ID: 27154182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rituximab for the treatment of non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
    Hagemeister F
    Drugs; 2010 Feb; 70(3):261-72. PubMed ID: 20166765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comprehensive approach to therapy of haematological malignancies in older patients.
    Cordoba R; Eyre TA; Klepin HD; Wildes TM; Goede V
    Lancet Haematol; 2021 Nov; 8(11):e840-e852. PubMed ID: 34624238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted therapy for hematologic malignancies.
    Kuriakose P
    Cancer Control; 2005 Apr; 12(2):82-90. PubMed ID: 15855891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Evidence-based Review of Anti-CD20 Antibody-containing Regimens for the Treatment of Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Diffuse Large B-cell Lymphoma, or Follicular Lymphoma.
    Falchi L; Ferrajoli A; Jacobs I; Nava-Parada P
    Clin Lymphoma Myeloma Leuk; 2018 Aug; 18(8):508-518.e14. PubMed ID: 29934061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization and outcomes of 414 patients with primary SS who developed haematological malignancies.
    Hernández-Molina G; Kostov B; Brito-Zerón P; Vissink A; Mandl T; Hinrichs AC; Quartuccio L; Baldini C; Seror R; Szántó A; Isenberg D; Gerli R; Nordmark G; Rasmussen A; Solans-Laque R; Hofauer B; Sène D; Pasoto SG; Rischmueller M; Praprotnik S; Gheita TA; Danda D; Armağan B; Suzuki Y; Valim V; Devauchelle-Pensec V; Retamozo S; Kvarnstrom M; Sebastian A; Atzeni F; Giacomelli R; Carsons SE; Kwok SK; Nakamura H; Fernandes Moça Trevisani V; Flores-Chávez A; Mariette X; Ramos-Casals M;
    Rheumatology (Oxford); 2022 Dec; 62(1):243-255. PubMed ID: 35385104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New directions in the diagnosis and treatment of chronic lymphocytic leukaemia.
    Schriever F; Huhn D
    Drugs; 2003; 63(10):953-69. PubMed ID: 12699399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Broadening the horizon: potential applications of CAR-T cells beyond current indications.
    Karsten H; Matrisch L; Cichutek S; Fiedler W; Alsdorf W; Block A
    Front Immunol; 2023; 14():1285406. PubMed ID: 38090582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeated transfusions of autologous cytokine-induced killer cells for treatment of haematological malignancies in elderly patients: a pilot clinical trial.
    Yang B; Lu XC; Yu RL; Chi XH; Liu Y; Wang Y; Dai HR; Zhu HL; Cai LL; Han WD
    Hematol Oncol; 2012 Sep; 30(3):115-22. PubMed ID: 22972689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphoma-like monoclonal B cell lymphocytosis in a patient population: biology, natural evolution, and differences from CLL-like clones.
    Vander Meeren S; Heyrman B; Renmans W; Bakkus M; Maes B; De Raeve H; Schots R; Jochmans K
    Ann Hematol; 2018 Jul; 97(7):1219-1227. PubMed ID: 29492600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HDAC6 Inhibition Alleviates CLL-Induced T-Cell Dysfunction and Enhances Immune Checkpoint Blockade Efficacy in the Eμ-TCL1 Model.
    Maharaj K; Powers JJ; Mediavilla-Varela M; Achille A; Gamal W; Quayle S; Jones SS; Sahakian E; Pinilla-Ibarz J
    Front Immunol; 2020; 11():590072. PubMed ID: 33329575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fourth biannual report of the Cochrane Haematological Malignancies Group.
    Kober T; Hülsewede H; Bohlius J; Engert A
    J Natl Cancer Inst; 2006 Apr; 98(8):E1. PubMed ID: 16622111
    [No Abstract]   [Full Text] [Related]  

  • 18. Bendamustine for the treatment of chronic lymphocytic leukemia and rituximab-refractory, indolent B-cell non-Hodgkin lymphoma.
    Dennie TW; Kolesar JM
    Clin Ther; 2009; 31 Pt 2():2290-311. PubMed ID: 20110042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic and clinical considerations in concomitant bone marrow involvement by plasma cell myeloma and chronic lymphocytic leukemia/monoclonal B-cell lymphocytosis: a series of 15 cases and review of literature.
    Alley CL; Wang E; Dunphy CH; Gong JZ; Lu CM; Boswell EL; Burchette J; Lagoo AS
    Arch Pathol Lab Med; 2013 Apr; 137(4):503-17. PubMed ID: 23544940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal B-cell lymphocytosis, monoclonal gammopathy of undetermined significance, and T-cell clones of uncertain significance: are these premalignant conditions sharing a common identity?
    Semenzato G; Ghobrial IM; Ghia P
    Lancet Haematol; 2023 Jul; 10(7):e549-e556. PubMed ID: 37407144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.